Titin-Based Force Modulates Cardiac Thick and Thin Filaments.

Autor: Hessel AL; Institute of Physiology II, University of Münster, Germany (A.L.H., M.N.K., J.K.F., W.A.L.)., Kuehn MN; Institute of Physiology II, University of Münster, Germany (A.L.H., M.N.K., J.K.F., W.A.L.)., Engels NM; Department of Cellular and Molecular Medicine, The University of Arizona, Tucson (N.M.E.)., Nissen DL; Biophysics Collaborative Access Team (BioCAT), Department of Biology, Illinois Institute of Technology, Chicago (D.L.N., W.M., T.C.I.)., Freundt JK; Institute of Physiology II, University of Münster, Germany (A.L.H., M.N.K., J.K.F., W.A.L.)., Ma W; Biophysics Collaborative Access Team (BioCAT), Department of Biology, Illinois Institute of Technology, Chicago (D.L.N., W.M., T.C.I.)., Irving TC; Biophysics Collaborative Access Team (BioCAT), Department of Biology, Illinois Institute of Technology, Chicago (D.L.N., W.M., T.C.I.)., Linke WA; Institute of Physiology II, University of Münster, Germany (A.L.H., M.N.K., J.K.F., W.A.L.).
Jazyk: angličtina
Zdroj: Circulation research [Circ Res] 2024 Apr 12; Vol. 134 (8), pp. 1026-1028. Date of Electronic Publication: 2024 Mar 14.
DOI: 10.1161/CIRCRESAHA.123.323988
Abstrakt: Competing Interests: Disclosures Unrelated efforts were provided to Edgewise Therapeutics (by T.C. Irving), AMB (by A.L. Hessel and M.N. Kuehn), and Dewpoint Therapeutics, Merck Sharp & Dohme, and Bristol Myers Squibb (by W.A. Linke). The other authors report no conflicts.
Databáze: MEDLINE